Extracorporeal shock wave therapy (ESWT) is recognized for its clinical efficacy in alleviating pain associated with prevalent musculoskeletal pathologies. Its mechanism involves the liberation of substance P from unmyelinated C-type nociceptive afferent fibers, which induces a transient antinociceptive effect and attenuates neurogenic inflammation within the targeted peripheral tissues. Consequently, this facilitates rapid symptomatic relief and enhances overall patient functional comfort.

Substance P release from irradiated tissue follows a time course that mirrors the clinical pattern of initial post-treatment discomfort followed by durable analgesia, and radial shockwave has shown measurable benefit in a sham-controlled acute low back pain trial.

☉ Hausdorf J, Schmitz C, Averbeck B, Maier M. Molecular basis for pain mediating properties of extracorporeal shock waves [in German]. Schmerz. 2004;18(6):492-497. doi:10.1007/s00482-003-0308-9

☉ Lange T, Deventer N, Gosheger G, Lampe LP, Bockholt S, Schulze Boevingloh A, Schulte TL. Effectiveness of radial extracorporeal shockwave therapy in patients with acute low back pain—randomized controlled trial. J Clin Med. 2021;10(23):5569. doi:10.3390/jcm10235569

Through the augmentation of regional microcirculation and the upregulation of cellular bioactivity, shockwave therapy expedites intrinsic tissue repair and regenerative cascades. This physiological mechanism renders it particularly advantageous for the management of acute traumatic lesions, chronic degenerative pathologies, and the facilitation of musculoskeletal restitution following strenuous athletic exertion.

Shockwave-induced neovascularization and increased topical blood perfusion have been documented as core mechanisms behind faster tissue repair, including in impaired (diabetic) healing models.

☉ Mittermayr R, Antonic V, Hartinger J, Kaufmann H, Redl H, Téot L, Stojadinovic A, Schaden W. Extracorporeal shock wave therapy (ESWT) for wound healing: technology, mechanisms, and clinical efficacy. Wound Repair Regen. 2012;20(4):456-465. doi:10.1111/j.1524-475X.2012.00796.x

☉ Kuo YR, Wang CT, Wang FS, Chiang YC, Wang CJ. Extracorporeal shock-wave therapy enhanced wound healing via increasing topical blood perfusion and tissue regeneration in a rat model of STZ-induced diabetes. Wound Repair Regen. 2009;17(4):522-530. doi:10.1111/j.1524-475X.2009.00504.x

Low-intensity extracorporeal shockwave therapy (Li-ESWT) constitutes a novel, non-invasive intervention for erectile dysfunction, Peyronie's disease, and chronic pelvic pain syndromes, with a therapeutic rationale centered on modulating the underlying pathophysiology of these disorders. The application of low-intensity, high-amplitude acoustic pressure waves is specifically intended to promote angiogenesis (neovascularization) and enhance local hemodynamic perfusion within penile cavernosal tissues. Mechanistically, the radial acoustic stimuli initiate a pleiotropic biological cascade, characterized by the upregulated secretion of angiogenic growth factors, which collectively stimulate cytoproliferation, potentiate tissue regeneration, and may facilitate the structural repair of microvascular endothelium.

Randomized, sham-controlled trials of low-intensity ESWT (Li-ESWT) targeting penile vascular tissue have shown IIEF score improvements attributed to angiogenesis and enhanced cavernosal perfusion.

☉ Ortac M, Özmez A, Cilesiz NC, Demirelli E, Kadıoğlu A. The impact of extracorporeal shock wave therapy for the treatment of young patients with vasculogenic mild erectile dysfunction: a prospective randomized single-blind, sham controlled study. Andrology. 2021;9(5):1571-1578. doi:10.1111/andr.13007 https://pubmed.ncbi.nlm.nih.gov/33780173/

☉ Kalyvianakis D, Mykoniatis I, Pyrgidis N, Kapoteli P, Zilotis F, Fournaraki A, Hatzichristou D. The effect of low-intensity shock wave therapy on moderate erectile dysfunction: a double-blind, randomized, sham-controlled clinical trial. J Urol. 2022;208(2):388-395. doi:10.1097/JU.0000000000002684 https://pubmed.ncbi.nlm.nih.gov/35830338/

Following shockwave therapy, patients frequently exhibit significant improvements in functional joint excursion and overall mobility. Such outcomes are particularly clinically relevant for individuals presenting with articular pathologies or restrictive musculoskeletal deficits.

Postoperative and rehabilitation trials show radial ESWT paired with standard therapy produces short-term gains in range of motion beyond rehabilitation alone, including in pediatric spasticity populations.

☉ Song Y, Che X, Wang Z, Li M, Zhang R, Wang D, Shi Q. A randomized trial of treatment for anterior cruciate ligament reconstruction by radial extracorporeal shock wave therapy. BMC Musculoskelet Disord. 2024;25(1):57. doi:10.1186/s12891-024-07177-8 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10787473/

☉ Khan MA, Aljohani NM, AlSehemi SA, Abdelhamid SA, Alahmadi OA, Altohami AY, Shweikan AA, Aljohani MK. Extracorporeal shockwave therapy for spasticity in children with cerebral palsy: a literature review of treatment protocols and outcome measurement parameters. Cureus. 2025;17(5):e84260. doi:10.7759/cureus.84260 https://pmc.ncbi.nlm.nih.gov/articles/PMC12168712/

Shockwave therapy facilitates the restorative remodeling of degenerated and lesional soft tissues, mechanistically inducing neovascularization (angiogenesis) while concurrently augmenting progenitor cell proliferation. This dual regenerative capacity positions the modality as a clinically promising intervention across a diverse spectrum of orthopedic and soft-tissue pathologies.

In vitro and in vivo studies show shockwave stimulation increases mesenchymal stem cell self-renewal, preserves multipotency, and accelerates cartilage repair when treated cells are transplanted.

☉ Zhang H, Li ZL, Yang F, Zhang Q, Su XZ, Li J, Zhang N, Liu CH, Mao N, Zhu H. Radial shockwave treatment promotes human mesenchymal stem cell self-renewal and enhances cartilage healing. Stem Cell Res Ther. 2018;9(1):54. doi:10.1186/s13287-018-0805-5 https://pubmed.ncbi.nlm.nih.gov/29523197/

☉ Schuh CM, Heher P, Weihs AM, Banerjee A, Fuchs C, Gabriel C, Wolbank S, Mittermayr R, Redl H, Rünzler D, Teuschl AH. In vitro extracorporeal shock wave treatment enhances stemness and preserves multipotency of rat and human adipose-derived stem cells. Cytotherapy. 2014;16(12):1666-1678. doi:10.1016/j.jcyt.2014.07.011 https://pubmed.ncbi.nlm.nih.gov/25174738/